<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Boston Scientific cuts guidance in wake of cyberattack, sees rebuilding years ahead — Live Feed</title><link>https://www.live-feeds.com/feed/boston-scientific-cuts-guidance-in-wake-of-cyberattack-sees-rebuilding-years-ahead</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/boston-scientific-cuts-guidance-in-wake-of-cyberattack-sees-rebuilding-years-ahead/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Boston Scientific Cuts Guidance Following Cyberattack</title><link>https://www.live-feeds.com/feed/boston-scientific-cuts-guidance-in-wake-of-cyberattack-sees-rebuilding-years-ahead</link><guid isPermaLink="false">https://www.live-feeds.com/feed/boston-scientific-cuts-guidance-in-wake-of-cyberattack-sees-rebuilding-years-ahead#u172239</guid><pubDate>Tue, 03 Nov 2026 13:01:45 +0000</pubDate><description>Boston Scientific lowered its financial guidance and slashed jobs after a cyberattack disrupted operations and triggered a double-digit drop in its stock price. The company reported third-quarter 2026 sales that exceeded initial expectations, but lowered its quarterly revenue guidance and adjusted earnings per share outlook. Management warned that rebuilding will take years, citing upcoming operational headwinds, pricing pressures in China, and weak demand for heart devices. Delayed product rollouts are expected to cause the company to cede market share through 2027.Why it mattersThe medical t</description></item>
</channel></rss>